logo-loader

Optibiotix Health eyes up future projects

Published: 08:40 20 Dec 2017 GMT

Per Rehne of Optibiotix Health (LON:OPTI) tells Proactive how the company's commercial journey through clinical trails, manufacturing and ultimately selling is a careful process of which he's been perfecting since he joined nine months ago. OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. Expanding the worldwide Optibiotix project portfolio is now the focus...hear how Per and the team intend to do just that.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

1 hour, 40 minutes ago